EPHA2 and breast carcinoma: E-cadherin plays a role in regulating the cell surface localization of EphA2 in breast cancer cells, and the loss of cell–cell contacts can impede interaction with ephrin ligands [101], making Eph receptor oncogenic activity appear to be ligand independent [50].